Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Medtech Bill Sponsor Sen. Isakson Retiring At Year’s End

Executive Summary

Sen. Johnny Isakson, R-GA, who has sponsored and backed several key pieces of device-industry legislation over the last several years, said on 28 August that he will retire from the US Senate on 31 December 2019, due to health challenges.

You may also be interested in...

Pathologists, Radiologists, Labs In Crosshairs As US Senate Panel Clears Lower Health Care Cost Act

The Senate HELP Committee has targeted “ancillary service providers” – radiologists, laboratorians, anesthesiologists and pathologists – who frequently serve health-care facilities on an out-of-network basis by requiring HHS rules to limit their reimbursements to the private payer in-network rate, as part of an effort to end surprise billing.

Medicare Looks To Speed Local Coverage Process For Medtech

The US Centers for Medicare and Medicaid Services has revised its local coverage determination manual to make the LCD process more transparent and responsive to the public. It’s intended as a first step to improving reimbursement processes for innovative therapies and devices, Medicare Chief Seema Verma said.

US House Panel Passes Bill To Bring More Transparency To Local Coverage Determination Process

The House Ways and Means Committee advanced legislation backed by the device industry to improve the transparency and accountability of the process Medicare Administrative Contractors use to make local coverage determinations for new medical technology.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts